Iovanace Biotherapeutics (IOVA) PT Lowered to $35 at Piper Sandler
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Price: $10.19 -4.23%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $35.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Ormat Technologies (ORA) PT Lowered to $104 at Jefferies
- OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB177 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
